Catheter ablation of atrial fibrillation in octogenarians: safety and outcomes

J Cardiovasc Electrophysiol. 2012 Jul;23(7):687-93. doi: 10.1111/j.1540-8167.2012.02293.x. Epub 2012 Apr 11.

Abstract

Introduction: Radiofrequency catheter ablation (RFCA) is an effective treatment for atrial fibrillation (AF), although studies evaluating the role of RFCA have largely excluded elderly patients. We report the safety and outcomes of RFCA of AF in octogenarians.

Methods and results: From 2008 to 2011, out of 2,754 consecutive patients undergoing RFCA of AF, 103 (3.7%) had ≥80 years (age 85 ± 3 years, 4 with >90 years). Pulmonary vein (PV) antrum isolation was performed in paroxysmal AF. In nonparoxysmal AF, ablation was extended to the entire left atrial posterior wall and to complex fractionated electrograms. Non-PV triggers were disclosed by isoproterenol challenge at the end of the procedure and targeted for ablation. Octogenarians presented a high rate of non-PV triggers (84% vs 69%, P = 0.001), especially in patients with paroxysmal AF (62% vs 19%, P < 0.001); non-PV triggers were most commonly mapped in the coronary sinus (54%), left atrial appendage (32%), interatrial septum and superior vena cava (14%). After a mean follow-up of 18 ± 6 months, 71 (69%) octogenarians remained free from AF recurrence off antiarrhythmic drugs after a single procedure (vs 71% in patients <80 years, P = 0.65). The success rate reached 87% after 2 procedures. Total periprocedural complication rates also did not differ between the 2 age groups.

Conclusions: RFCA of AF is safe and effective in octogenarians. A high rate of non-PV triggers is present in these patients, and targeting multiple structures other than the pulmonary veins is often necessary to achieve long-term success.

Publication types

  • Comparative Study

MeSH terms

  • Age Factors
  • Aged
  • Aged, 80 and over
  • Anti-Arrhythmia Agents / therapeutic use
  • Atrial Appendage / physiopathology
  • Atrial Appendage / surgery
  • Atrial Fibrillation / diagnosis
  • Atrial Fibrillation / physiopathology
  • Atrial Fibrillation / surgery*
  • Atrial Septum / physiopathology
  • Atrial Septum / surgery
  • Catheter Ablation* / adverse effects
  • Coronary Sinus / physiopathology
  • Coronary Sinus / surgery
  • Electrophysiologic Techniques, Cardiac
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Predictive Value of Tests
  • Pulmonary Veins / physiopathology
  • Pulmonary Veins / surgery
  • Recurrence
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors
  • Time Factors
  • Treatment Outcome
  • Vena Cava, Superior / physiopathology
  • Vena Cava, Superior / surgery

Substances

  • Anti-Arrhythmia Agents